Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aviv Pharmaceuticals is an Israel-based pharmaceutical company specializing in the development and commercialization of medical cannabis products. Founded by a team of former executives from Teva Pharmaceutical Industries, the company aims to standardize the medical cannabis industry by applying rigorous pharmaceutical-grade manufacturing and clinical validation processes. Aviv's product line includes specialized delivery systems such as oils, inhalers, and capsules designed for precise dosing and consistent therapeutic effects. The company focuses on a variety of therapeutic areas, including chronic pain management, sleep disorders, and mental health conditions like anxiety and PTSD. Aviv Pharmaceuticals operates a GMP-certified facility and is committed to advancing the science of cannabinoid-based medicine through ongoing research and development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aviv Pharma.